Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model-Reference-Cited by-同舟云学术

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

Published:2023-09 Issue: Volume:63 Page:102150
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Rentroia-Pacheco Barbara^ORCID,Tokez Selin,Bramer Edo M.,Venables Zoe C.,van de Werken Harmen J.G.^ORCID,Bellomo Domenico^ORCID,van Klaveren David,Mooyaart Antien L.,Hollestein Loes M.,Wakkee Marlies^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference49 articles.

1. Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: a nationwide cancer registry study;Tokez;J Am Acad Dermatol,2022

2. The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990–2017;Urban;JAAD Int,2021

3. The current treatment landscape of cutaneous squamous cell carcinoma;Chong;Am J Clin Dermatol,2023

4. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012;Karia;J Am Acad Dermatol,2013

5. The landscape of driver mutations in cutaneous squamous cell carcinoma;Chang;NPJ Genom Med,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case–Control Study;Cancers;2024-06-15

2. Improving risk classification in cutaneous squamous cell carcinoma;Medicom Conference Report DDD 2024;2024-05-31

3. Weighted metrics are required when evaluating the performance of prediction models in nested case–control studies;BMC Medical Research Methodology;2024-05-17